SRNE logo

Sorrento Therapeutics (SRNE) Operating Margin

SRNE Annual Operating Margin

-602.33%
+93.35%+13.42%

31 December 2022

SRNE Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRNE Quarterly Operating Margin

-510.93%
+35.79%+6.55%

30 June 2023

SRNE Quarterly Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRNE Operating Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.4%+6.5%
3 y3 years+3.0%+6.5%
5 y5 years-1878.4%+6.5%

SRNE Operating Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+13.4%at high+36.3%
5 y5-year-19.5%+13.4%-52.5%+36.3%
alltimeall time-1878.4%+82.3%-767.3%+91.9%

Sorrento Therapeutics Operating Margin History

DateAnnualQuarterly
June 2023
-
-510.93%(-6.5%)
Mar 2023
-
-546.72%(+6.9%)
Dec 2022
-602.33%(-13.4%)
-511.51%(-19.2%)
Sept 2022
-
-633.01%(-21.0%)
June 2022
-
-801.68%(+52.4%)
Mar 2022
-
-526.03%(-34.4%)
Dec 2021
-695.68%(+38.0%)
-802.32%(+7.2%)
Sept 2021
-
-748.32%(+5.9%)
June 2021
-
-706.68%(+30.2%)
Mar 2021
-
-542.92%(-7.2%)
Dec 2020
-503.99%(-18.8%)
-584.93%(+42.6%)
Sept 2020
-
-410.28%(-13.8%)
June 2020
-
-475.71%(-14.9%)
Mar 2020
-
-559.03%(+66.9%)
Dec 2019
-620.97%(+1.6%)
-335.04%(-63.7%)
Sept 2019
-
-922.17%(+18.6%)
June 2019
-
-777.54%(-0.2%)
Mar 2019
-
-779.24%(+23.2%)
Dec 2018
-610.94%(-1903.8%)
-632.50%(-32.4%)
Sept 2018
-
-935.35%(+35.9%)
June 2018
-
-688.32%(+111.6%)
Mar 2018
-
-325.33%(+5259.6%)
Dec 2017
33.87%(-104.6%)
-6.07%(-107.9%)
Sept 2017
-
76.57%(-120.9%)
June 2017
-
-366.28%(-24.3%)
Mar 2017
-
-483.94%(-1.5%)
DateAnnualQuarterly
Dec 2016
-734.76%(-32.5%)
-491.17%(-20.9%)
Sept 2016
-
-621.31%(-61.3%)
June 2016
-
-1603.99%(+34.8%)
Mar 2016
-
-1189.68%(-10.2%)
Dec 2015
-1089.15%(+20.6%)
-1324.98%(+26.3%)
Sept 2015
-
-1048.69%(+16.8%)
June 2015
-
-897.95%(-13.8%)
Mar 2015
-
-1041.66%(-14.7%)
Dec 2014
-902.82%(-73.5%)
-1221.30%(+118.5%)
Sept 2014
-
-558.86%(-45.8%)
June 2014
-
-1031.10%(+4.1%)
Mar 2014
-
-990.27%(-84.3%)
Dec 2013
-3409.13%(+310.3%)
-6291.09%(+57.9%)
Sept 2013
-
-3984.34%(+61.3%)
June 2013
-
-2469.72%(+31.6%)
Mar 2013
-
-1876.12%(+30.6%)
Dec 2012
-830.82%(+35.6%)
-1437.02%(+55.5%)
Sept 2012
-
-924.38%(+112.4%)
June 2012
-
-435.16%(-47.2%)
Mar 2012
-
-823.97%(+38.1%)
Dec 2011
-612.72%(+130.8%)
-596.78%(-22.2%)
Sept 2011
-
-766.89%(-47.8%)
June 2011
-
-1469.03%(+404.0%)
Mar 2011
-
-291.50%(+690.4%)
Dec 2010
-265.49%
-36.88%(-90.5%)
Sept 2010
-
-389.69%(-61.8%)
June 2010
-
-1020.97%

FAQ

  • What is Sorrento Therapeutics annual operating profit margin?
  • What is the all time high annual operating margin for Sorrento Therapeutics?
  • What is Sorrento Therapeutics annual operating margin year-on-year change?
  • What is Sorrento Therapeutics quarterly operating profit margin?
  • What is the all time high quarterly operating margin for Sorrento Therapeutics?
  • What is Sorrento Therapeutics quarterly operating margin year-on-year change?

What is Sorrento Therapeutics annual operating profit margin?

The current annual operating margin of SRNE is -602.33%

What is the all time high annual operating margin for Sorrento Therapeutics?

Sorrento Therapeutics all-time high annual operating profit margin is 33.87%

What is Sorrento Therapeutics annual operating margin year-on-year change?

Over the past year, SRNE annual operating profit margin has changed by +93.35% (+13.42%)

What is Sorrento Therapeutics quarterly operating profit margin?

The current quarterly operating margin of SRNE is -510.93%

What is the all time high quarterly operating margin for Sorrento Therapeutics?

Sorrento Therapeutics all-time high quarterly operating profit margin is 76.57%

What is Sorrento Therapeutics quarterly operating margin year-on-year change?

Over the past year, SRNE quarterly operating profit margin has changed by +35.79% (+6.55%)